Nabla Bio vs Syandus: Revenue, Funding & Team Size Compared
Last updated
Nabla Bio generates $1.2M in revenue; Syandus generates $1.2M. Syandus and Nabla Bio are close to the same size by revenue. The table below compares Nabla Bio and Syandus on funding, valuation, customers, team size and headquarters — every figure GetLatka has verified for each company.
| Company |  Nabla BioThis company |  Syandus |
|---|---|---|
| Revenue | $1.2M | $1.2M |
| Funding raised | Not disclosed | $1.3M |
| Team size | 8 | 11 |
| Founded | 2020 | 2008 |
| HQ | Boston, United States | Exton, United States |
Want the full dataset? GetLatka tracks revenue, funding and team history for thousands of SaaS companies, with charts, growth rates and founder interviews.
Nabla Bio at a glance
Nabla Bio generates $1.2M in revenue with 8 employees, headquartered in Boston, United States.
- Revenue
- $1.2M
- Team size
- 8
- Founded
- 2020
We use AI to design antibodies for intractable diseases
Syandus at a glance
Syandus generates $1.2M in revenue with 11 employees, headquartered in Exton, United States.
- Revenue
- $1.2M
- Funding
- $1.3M
- Team size
- 11
- Founded
- 2008
🚀 ALIVESIM PLATFORM Create immersive decision scenarios that drive performance. ⚡ OUR TECHNOLOGY AliveSim is an AI-powered platform that transforms how organizations develop expertise through structured practice. Our technology enables…
Other Nabla Bio alternatives
Nabla Bio competes with more than the companies on this page. Browse the full alternative lists to compare revenue, funding and team size across the category.
Nabla Bio vs Syandus: frequently asked questions
Is Nabla Bio or Syandus bigger?
Syandus is the bigger company by revenue, at $1.2M against $1.2M for Nabla Bio.
How much revenue does Nabla Bio make?
Nabla Bio generates $1.2M in annual revenue with a team of 8.
How much revenue does Syandus make?
Syandus generates $1.2M in annual revenue with a team of 11.
How much funding has Syandus raised?
Syandus has raised $1.3M in total funding since it was founded in 2008.